Sökresultat - Sanson, M

Cases Illustrative of the Different Methods of Operating for the Stone av Dupuytren, M., Sanson, M.

Hämta fulltext Hämta fulltext

Glioblastoma targeted therapy: updated approaches from recent biological insights av Touat, M., Idbaih, A., Sanson, M., Ligon, K. L.

Hämta fulltext Hämta fulltext Hämta fulltext

Dramatic improvement in non-AIDS related progressive multifocal leucoencephalopathy av Aure, K, Behin, A, Louillet, F, Lafitte, C, Sanson, M, Vernant, J

Hämta fulltext Hämta fulltext Hämta fulltext

PL02.4.A Chromosome 1p19q codeletion frequency, but not survival, varies according to the IDH mutation subtypes: analysis of 1050 IDH-mutated diffuse gliomas av Picca, A, Berzero, G, Di Stefano, A, Trabelsi, N, Bielle, F, Sanson, M

Hämta fulltext Hämta fulltext

Parental origin of chromosome 22 alleles lost in meningioma. av Sanson, M, Delattre, O, Couturier, J, Philippon, J, Cophignon, J, Derome, P, Rouleau, G A, Thomas, G

Hämta fulltext Hämta fulltext

P04.14 IDH1 MUTATION IN LOW-GRADE GLIOMAS RELATED TO EPILEPSY AS INITIAL SYMPTOM av Duran-Peña, A., Mokhtari, K., Marie, Y., Alentorn, A., Delattre, J., Idbaih, A., Sanson, M., Vecht, C.

Hämta fulltext Hämta fulltext

O8.08 CIC MUTATION IS A POOR PROGNOSIS FACTOR IN 1P19Q CODELETED GLIOMAS, ASSOCIATED TO AN UP-REGULATION OF PROLIFERATION PATHWAYS av Gleize, V., Alentorn, A., Connen de Kérillis, L., Labussière, M., Mangesius, S., Ducray, F., Mokhtari, K., Villa, C., Sanson, M.

Hämta fulltext Hämta fulltext

OS6.6 CEVOREM Trial: Combination of EVerolimus and Octreotide in REsistant MeningiomasPresentation and Preliminary results av Graillon, T., Peyre, M., Kalamarides, M., Sanson, M., Barrié, M., Campello, C., Tabouret, E., Roche, P., Dufour, H., Chinot, O.

Hämta fulltext Hämta fulltext

P04.10 IDH-wildtype low grade gliomas: overall survival and prognostic indicators av Berzero, G, Di Stefano, A, Ronchi, S, Villa, C, Marie, Y, Hoang-Xuan, K, Delattre, J, Mokhtari, K, Sanson, M

Hämta fulltext Hämta fulltext

P08.63 Dose optimization of MK-8628 (OTX015), a small molecule inhibitor of bromodomain and extra-terminal (BET) proteins, in patients with recurrent glioblastoma av Hottinger, A. F., Sanson, M., Moyal, E., Delord, J., Rezai, K., Leung, A., Perez, S., Bekradda, M., Lachaux, N., Chinot, O.

Hämta fulltext Hämta fulltext

P05.02 KIAA1549:BRAF FUSION GENE IN PEDIATRIC BRAIN TUMORS OF VARIOUS HISTOGENESIS av Baldi, C., Antonelli, M., Badiali, M., Buttarelli, F.R., Moi, L., Nozza, P., Arcella, A., Massimino, M., Sanson, M., Giangaspero, F.

Hämta fulltext Hämta fulltext

O6.08 COMBINED ANALYSIS OF TERT, EGFR AND IDH STATUS DEFINE DISTINCT PROGNOSTIC CLASSES OF GLIOBLASTOMA av Labussiere, M., Boisselier, B., Mokhtari, K., Di Stefano, A., Rahimian, A., Saulnier, O., Paterra, R., Finocchiaro, G., Marie, Y., Sanson, M.

Hämta fulltext Hämta fulltext

P01.148 Intra-tumor heterogeneity analysis of low-grade gliomas. A POLA Network study av Alentorn, A, Labreche, K, Dehais, C, Carpentier, C, Ducray, F, Mokhtari, K, Figarella-Branger, D, Sanson, M, Delattre, J, Idbaih, A

Hämta fulltext Hämta fulltext

O6.07 FGFR3-TACC3 AND EGFR-SEPT14 GENE FUSIONS IN ADULT GLIOMAS av Di Stefano, A. L., Labussiere, M., Frattini, V., Fucci, A., Boisselier, B., Schmitt, Y., Mokhtari, K., Lasorella, A., Iavarone, A., Sanson, M.

Hämta fulltext Hämta fulltext

P06.18 DNA methylation distance score in lower-grade gliomas has prognostic value: a POLA network study av Alentorn, A., Kamoun, A., Ducray, F., Dehais, C., Mokhtari, K., Uro-Coste, E., Figarella-Branger, D., Delattre, J., Idbaih, A., Sanson, M.

Hämta fulltext Hämta fulltext

P07.15 Diagnostic value of 2-hydroxyglutarate detection by 1H MR spectroscopy in patients with glioma and correlations with tumor phenotype and tissue dosage av Di Stefano, A. L., Branzoli, F., Ottolenghi, C., Capelle, L., Mokhtari, K., Villa, C. M., Giry, M., Marjanska, M., Lehericy, S., Sanson, M.

Hämta fulltext Hämta fulltext

P09.14 Clonal and subclonal evolution of 1p/19q co-deleted oligodendrogliomas av Alentorn, A., Daniau, M., Royer-Perron, L., Labreche, K., Duran-Pena, A., Marie, Y., Hoang-Xuan, K., Sanson, M., Delattre, J., Idbaih, A.

Hämta fulltext Hämta fulltext

EH1.1 Results of the interim analysis of the EORTC randomized phase III CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q co-deletion, an int... av van den Bent, M. J., Erridge, S., Vogelbaum, M., Nowak, A., Sanson, M., Brandes, A. A., Golfinopoulos, V., Gorlia, T., Kros, J. M., Baumert, B. G.

Hämta fulltext Hämta fulltext

P01.12 Stability of actionable mutations in primary and recurrent glioblastomas av French, P. J., Taphoorn, M., Weyerbrock, A., Sanson, M., Hoeben, A., Lukavoca, S., Lombardi, G., Hanse, M., Watts, C., Golfinopoulos, V., McDermott, U., Robe, P.

Hämta fulltext Hämta fulltext

OS8.5 How to assess meningioma therapy activity: The CEVOREM independent central review experience av GRAILLON, T, Colin, T, Peyrière, H, Peyre, M, Tabouret, E, Campello, C, Idbaih, A, Boucekine, M, Figarella-Branger, D, Kalamarides, M, Dufour, H, Sanson, M, Chinot, O

Hämta fulltext Hämta fulltext